Outcomes of COVID-19 re-infections: a single-center cohort of 167 patients with systemic rheumatic diseases

被引:0
作者
Panagiotopoulos, Alexandros [1 ]
Fragoulis, George E. [1 ]
Arida, Aikaterini [1 ]
Bournia, Vassiliki-Kalliopi [1 ]
Evangelatos, Gerasimos [1 ]
Fragkiadaki, Kalliopi [1 ]
Kravvariti, Evrydiki [1 ]
Laskari, Katerina [1 ]
Mylona, Maria [1 ]
Michalakeas, Nikolaos [1 ]
Papazoglou, Nikolaos [1 ]
Pappa, Maria [1 ]
Poulia, Vassiliki [1 ]
Panopoulos, Stylianos [1 ]
Ziarangali, Sevastiani [1 ]
Papatheodorou, Vasileios [1 ]
Tektonidou, Maria G. [1 ]
Sfikakis, Petros P. [1 ]
机构
[1] Natl & Kapodistrian Univ Athens, Joint Acad Rheumatol Program, Dept Propaedeut Internal Med, Sch Med, Mikras Asias 75 Str, Athens, Greece
关键词
Rheumatic diseases; COVID-19; Re-infections;
D O I
10.1007/s00296-024-05573-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Data on COVID-19 re-infections in patients with systemic rheumatic diseases (SRDs) are lacking. We aimed to describe the course and outcomes of COVID-19 re-infections in these patients versus controls. In this single-center retrospective study, we included 167 consecutive SRD patients with at least one COVID-19 re-infection (mean age 47.3 years, females 70.7%). SRD patients were compared in terms of patient-perceived COVID-19 re-infection severity and hospitalizations/deaths with 167 age/sex-matched non-SRD controls. Logistic regression analysis was performed to assess potential milder re-infection versus primary infection severity, adjusting for study group, demographics (age, sex), vaccination status, body mass index, smoking, and comorbidities. 23 and 7 out of 167 re-infected SRD patients experienced two and three re-infections, respectively, which were comparable to the re-infection rates in controls (two: 32; and three: 2) who also had comparable COVID-19 vaccination history (89% and 95% vaccinated, respectively). In the initial infection, patients with SRDs were hospitalized (7.2% versus 1.8%, p = 0.017), and had received antiviral treatment (16.1% versus 4.7%, p < 0.001) more frequently than controls. However, hospitalizations (1.8% vs 0.6%) and antiviral treatment (7.8% vs 3.5%) did not differ (p > 0.05) between patients and controls at the first re-infection, as well as during the second and third re-infection; no deaths were recorded. Perceived severity of re-infections was also comparable between patients and controls (p = 0.847) and among those on biologic DMARDs or not (p = 0.482). In multivariable analysis, neither SRDs presence nor demographics or comorbidities were associated with COVID-19 re-infection severity. COVID-19 re-infection severity (patient-perceived/hospitalizations/deaths) did not differ between SRDs and controls.
引用
收藏
页码:1733 / 1737
页数:5
相关论文
共 23 条
[1]   Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression [J].
Bobrovitz, Niklas ;
Ware, Harriet ;
Ma, Xiaomeng ;
Li, Zihan ;
Hosseini, Reza ;
Cao, Christian ;
Selemon, Anabel ;
Whelan, Mairead ;
Premji, Zahra ;
Issa, Hanane ;
Cheng, Brianna ;
Abu Raddad, Laith J. ;
Buckeridge, David L. ;
Van Kerkhove, Maria D. ;
Piechotta, Vanessa ;
Higdon, Melissa M. ;
Wilder-Smith, Annelies ;
Bergeri, Isabel ;
Feikin, Daniel R. ;
Arora, Rahul K. ;
Patel, Minal K. ;
Subissi, Lorenzo .
LANCET INFECTIOUS DISEASES, 2023, 23 (05) :556-567
[2]   Outcomes of COVID-19 Omicron variant in patients with rheumatoid arthritis: a nationwide Greek cohort study [J].
Bournia, Vasiliki-Kalliopi ;
Fragoulis, George E. ;
Mitrou, Panagiota ;
Mathioudakis, Konstantinos ;
Konstantonis, George ;
Tektonidou, Maria G. ;
Tsolakidis, Anastasios ;
Paraskevis, Dimitrios ;
Sfikakis, Petros P. .
RHEUMATOLOGY, 2023, :1130-1138
[3]   Different COVID-19 outcomes among systemic rheumatic diseases: a nation-wide cohort study [J].
Bournia, Vasiliki-Kalliopi ;
Fragoulis, George E. ;
Mitrou, Panagiota ;
Mathioudakis, Konstantinos ;
Tsolakidis, Anastasios ;
Konstantonis, George ;
Tseti, Ioulia ;
Vourli, Georgia ;
Tektonidou, Maria G. ;
Paraskevis, Dimitrios ;
Sfikakis, Petros P. .
RHEUMATOLOGY, 2023, 62 (03) :1047-1056
[4]   Psychometric evaluation of the Symptoms of Infection with Coronavirus-19 (SIC): results from a cross-sectional study and a phase 3 clinical trial [J].
Chan, Eric K. H. ;
Williams, Valerie ;
Romano, Carla ;
Fehnel, Sheri ;
Slagle, Ashley F. ;
Stoddard, Jeffrey ;
Sadoff, Jerald ;
Mayorga, Margaret ;
Lewis, Sandy ;
Yarr, Stuart ;
Ma, Jia ;
Liu, Yan ;
Katz, Eva G. ;
McNulty, Pauline ;
van Dromme, Ilse ;
McQuarrie, Kelly .
JOURNAL OF PATIENT-REPORTED OUTCOMES, 2023, 7 (01)
[5]   SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta-analysis [J].
Conway, Richard ;
Grimshaw, Alyssa A. ;
Konig, Maximilian F. ;
Putman, Michael ;
Duarte-Garcia, Ali ;
Tseng, Leslie Yingzhijie ;
Cabrera, Diego M. ;
Chock, Yu Pei Eugenia ;
Degirmenci, Huseyin Berk ;
Duff, Eimear ;
Egeli, Bugra Han ;
Graef, Elizabeth R. ;
Gupta, Akash ;
Harkins, Patricia ;
Hoyer, Bimba F. ;
Jayatilleke, Arundathi ;
Jin, Shangyi ;
Kasia, Christopher ;
Khilnani, Aneka ;
Kilian, Adam ;
Kim, Alfred H. J. ;
Lin, Chung Mun Alice ;
Low, Candice ;
Proulx, Laurie ;
Sattui, Sebastian E. ;
Singh, Namrata ;
Sparks, Jeffrey A. ;
Tam, Herman ;
Ugarte-Gil, Manuel F. ;
Ung, Natasha ;
Wang, Kaicheng ;
Wise, Leanna M. ;
Yang, Ziyi ;
Young, Kristen J. ;
Liew, Jean W. ;
Grainger, Rebecca ;
Wallace, Zachary S. ;
Hsieh, Evelyn .
ARTHRITIS & RHEUMATOLOGY, 2022, 74 (05) :766-775
[6]   Clinical characteristics and outcomes of COVID-19 breakthrough infections among vaccinated patients with systemic autoimmune rheumatic diseases [J].
Cook, Claire ;
Patel, Naomi J. ;
D'Silva, Kristin M. ;
Hsu, Tiffany Y-T ;
Dilorio, Michael ;
Prisco, Lauren ;
Martin, Lily W. ;
Vanni, Kathleen ;
Zaccardelli, Alessandra ;
Todd, Derrick ;
Sparks, Jeffrey A. ;
Wallace, Zachary Scott .
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (02) :289-291
[7]  
Deng Jie, 2023, Int J Environ Res Public Health, V20, DOI 10.3390/ijerph20043335
[8]  
Feikin DR, 2022, LANCET, V399, P924, DOI 10.1016/S0140-6736(22)00152-0
[9]   Oral antiviral treatment in patients with systemic rheumatic disease at risk for development of severe COVID-19: a case series [J].
Fragoulis, George E. ;
Koutsianas, Christos ;
Fragiadaki, Kalliopi ;
Mariolis, Ilias ;
Panopoulos, Stylianos ;
Tsalapaki, Christina ;
Pappa, Maria ;
Dimitroulas, Theodoros ;
Tektonidou, Maria G. ;
Vassilopoulos, Dimitrios ;
Sfikakis, Petros P. .
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (10) :1477-1479
[10]   Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases [J].
Fragoulis, George E. ;
Karamanakos, Anastasios ;
Arida, Aikaterini ;
Bournia, Vasiliki-Kalliopi ;
Evangelatos, Gerasimos ;
Fanouriakis, Antonis ;
Fragiadaki, Kalliopi ;
Kravvariti, Evrydiki ;
Laskari, Katerina ;
Panopoulos, Stylianos ;
Papazoglou, Nikolaos ;
Pappa, Maria ;
Tektonidou, Maria G. G. ;
Sfikakis, Petros P. .
RMD OPEN, 2022, 8 (01)